ASCO 2015 Highlights

It started with a bit of blood.

Although biomarker-driven targeted therapies for gastric cancer have advanced significantly, many eligible patients are not receiving these treatments, highlighting the urgent need to overcome barriers such as insufficient biomarker testing and socioeconomic disparities.

Iman Ahmed, PharmD, BCOP, recently discussed the evidence for what’s actually contributing to health inequities in hematologic malignancies, and how providers can mitigate these disparities.

Healthcare deserts are regions in the United States with limited access to healthcare providers and medicine, often contributing to poor health outcomes and healthcare inequities for residents of these communities.

Learn about how clinical research trials are revolutionizing radiotherapy, leading to advancements reshaping cancer care for better patient outcomes and experiences.

A coalition of more than 40 health insurers recently announced plans for prior authorization reform.